Loading clinical trials...

Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars | Clinical Trials | Clareo Health

COMPLETEDNA

Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars

NCT02103127•Cynosure, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess treatment of facial acne scars using the 755nm Alexandrite Laser with lens arrays.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Is a healthy male or female between 18 and 65 years old
•2. Has unwanted acne scars, excluding ice pick scars (Deep atrophic scars that resemble poked holes), and wishes to undergo laser treatments.
•3. Is willing to consent to participate in the study.
•4. Is willing to comply with all requirements of the study including biopsies, being photographed, following post treatment care and attending all treatment and follow up visits.

Exclusion Criteria

•1. The subject is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding or planning a pregnancy during the study period.
•2. The subject is hypersensitive to light exposure OR takes photo sensitized medication.
•3. The subject has active or localized systemic infections.
•4. The subject has a coagulation disorder or is currently using anti-coagulation medication (including but not limited to heavy aspirin therapy {greater than 81 mg per day}).
•5. The subject has any condition which, in the investigator's opinion, would make it unsafe for the subject to participate in this research study.
•6. The subject is currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within 3 months prior to entering this study.
•7. The subject has used Accutane within 6 months prior to enrollment.
•8. The subject has the need to be exposed to artificial tanning devices or excessive sunlight during the trial.
•9. The subject has had prior treatment with parenteral gold therapy (gold sodium thiomalate).
•10. The subject has a history of keloids.
+4 more criteria

Locations (1)

Laser & Skin Surgery Center of Northern California

Sacramento, California, United States

Key Dates

Start Date

July 1, 2013

Primary Completion Date

May 1, 2015

Completion Date

May 1, 2015

Last Updated

January 15, 2021

Enrollment

ACTUAL participants

Conditions

Acne Scars

Interventions

755nm Alexandrite laser with lens array

DEVICE

Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars

NCT07058883

Acne Scars

View study

RECRUITINGNA

The Suitability of Tience® for Treating Acne Scars

NCT07368764

AcneAcne Scars

View study

RECRUITINGNA

Efficacy of Combined Fractional Er:Glass and Thulium Lasers Versus Microneedling for Atrophic Acne Scars

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 15, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars

Inclusion Criteria

Exclusion Criteria

Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars

The Suitability of Tience® for Treating Acne Scars

Efficacy of Combined Fractional Er:Glass and Thulium Lasers Versus Microneedling for Atrophic Acne Scars

Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions

The MIRIA Acne Scar Study

Microneedling Combined With Either Tranexamic Acid or PRP in Treatment of Pigmented Postacne Scars